All In Biotech

Drug Trial Radar · NCT04675333

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

A Phase 2 Study of ALX148 in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

Last checked: Nov 19, 2026Latest source record: Aug 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 172 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

172

Actual

Start

May 10, 2021

Primary completion

Mar 3, 2025

Study completion Jun 30, 2026

Sponsor

Lead sponsor
ALX Oncology Inc.Industry
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Dec 19, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma.

Conditions

  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma

Interventions

  • evorpaceptDrug

    IV Q3W

  • pembrolizumabDrug

    IV Q3W

  • Cisplatin/Carboplatin; 5FUDrug

    IV Q3W

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective response rate per RECIST 1.1Time frame: Last randomized patient reaching at least 24 weeks of follow-up

Locations

44 sites in 8 countries. Site status is shown where the registry gives one.

  • Hoag Hospital

    Irvine, California

  • University of California San Diego

    La Jolla, California

  • Cedar Sinai Medical Center

    Los Angeles, California

  • University of Miami, Sylvester Comprehensive Cancer Center

    Miami, Florida

  • Moffitt Cancer Center

    Tampa, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • University of Louisville

    Louisville, Kentucky

  • University of Maryland Medical System

    Baltimore, Maryland

  • Memorial Sloan Kettering

    New York, New York

  • The Ohio State University

    Columbus, Ohio

  • Oregon Health & Science University/ Knight Cancer Institute

    Portland, Oregon

  • Vanderbilt - Ingram Cancer Center

    Nashville, Tennessee

  • Houston Methodist Cancer Center

    Houston, Texas

  • Sir Charles Gairdner Hospital

    Nedlands, Australia

  • Royal Brisbane and Womens Hospital

    Herston, Queensland, Australia

  • Ashford Cancer Centre

    Adelaide, South Australia, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • AZ Groeninge

    Kortrijk, Belgium

  • Amsterdam UMC, Locatie VUMC

    Amsterdam, Netherlands

  • Universitair Medisch Centrum Groningen

    Groningen, Netherlands

  • National University Cancer Institute

    Singapore, Singapore

  • National Cancer Centre Singapore

    Singapore, Singapore

  • Chungbuk National University Hospital

    Cheongju-si, South Korea

  • Yeungnam University Medical Center

    Daegu, South Korea

  • Gachon University (GCU) - Gil Medical Center (Gil Hospital)

    Incheon, South Korea

  • Seoul National University, Bundang Hospital

    Seongnam, South Korea

  • CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center)

    Seongnam-si, South Korea

  • The Catholic University of Korea - Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Institut Catala d Oncologia (ICO)

    Badalona, Spain

  • Institut Catala dOncologia

    L'Hospitalet de Llobregat, Spain

  • Hospital Universitario Severo Ochoa

    Leganés, Spain

  • Grupo Hospital de Madrid (HM) - Hospital Universitario Madrid Sanchinarro - Cent

    Madrid, Spain

  • Hospital Universitario La Paz

    Madrid, Spain

  • Hospital Regional Universitario de Malaga

    Málaga, Spain

  • Hospital Universitario de Navarra

    Pamplona, Spain

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.